Thyroid Diseases
Welcome,         Profile    Billing    Logout  
 62 Companies   89 Products   89 Products   76 Mechanisms of Action   2 Trials   652 News 


«12345678910111213...1314»
  • ||||||||||  Trial completion, Trial primary completion date:  Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy (clinicaltrials.gov) -  Oct 21, 2015   
    P3,  N=1203, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Aug 2015
  • ||||||||||  Trial completion:  SORTED: Study of Optimal Replacement of Thyroxine in the Elderly (clinicaltrials.gov) -  Oct 13, 2015   
    P4,  N=48, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: May 2014 --> Aug 2015 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, Metastases:  Study of External Beam Radiotherapy to Thyroid Carcinoma (clinicaltrials.gov) -  Oct 7, 2015   
    P2,  N=62, Completed, 
    Recruiting --> Completed Recruiting --> Completed | N=50 --> 62 | Trial primary completion date: Dec 2015 --> Aug 2015
  • ||||||||||  Trial primary completion date:  The Observer Variation of Shear Wave Elastography (clinicaltrials.gov) -  Sep 24, 2015   
    P=N/A,  N=30, Recruiting, 
    Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Tepezza (teprotumumab-trbw) / Roche, Amgen
    Enrollment closed, Trial primary completion date:  Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) -  Sep 22, 2015   
    P2,  N=84, Active, not recruiting, 
    N=80 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Sep 2017 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016
  • ||||||||||  thyroxine / Generic mfg.
    Trial withdrawal:  Levothyroxine in Pregnant SLE Patients (clinicaltrials.gov) -  Sep 10, 2015   
    P4,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016 Terminated --> Withdrawn
  • ||||||||||  Enrollment change, Trial initiation date, Trial primary completion date:  Thyroid Hormone Replacement for Subclinical Hypothyroidism (clinicaltrials.gov) -  Jul 6, 2015   
    P4,  N=540, Recruiting, 
    Active, not recruiting --> Completed N=3000 --> 540 | Initiation date: Feb 2013 --> May 2014 | Trial primary completion date: Jun 2016 --> Nov 2016
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Trial completion, Enrollment change:  CaprelsaReg: CAPRELSA (clinicaltrials.gov) -  Jul 6, 2015   
    P=N/A,  N=10, Completed, 
    N=3000 --> 540 | Initiation date: Feb 2013 --> May 2014 | Trial primary completion date: Jun 2016 --> Nov 2016 Recruiting --> Completed | N=15 --> 10
  • ||||||||||  Trial initiation date, Trial primary completion date, Surgery:  Acupuncture for Reduction of Inflammation (clinicaltrials.gov) -  Jun 12, 2015   
    P=N/A,  N=20, Completed, 
    Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Nov 2014 Initiation date: Mar 2013 --> Jul 2013 | Trial primary completion date: Oct 2014 --> Jul 2014
  • ||||||||||  dexamethasone / Generic mfg.
    Trial primary completion date, Surgery:  Dexamethasone and Wound Healing After Thyroid Surgery (clinicaltrials.gov) -  Jun 11, 2015   
    P=N/A,  N=150, Recruiting, 
    Initiation date: Mar 2013 --> Jul 2013 | Trial primary completion date: Oct 2014 --> Jul 2014 Trial primary completion date: Dec 2014 --> Jun 2015
  • ||||||||||  Trial completion, Enrollment change, IO biomarker:  Autoimmune Thyroid Disease Genetic Study (clinicaltrials.gov) -  May 28, 2015   
    P=N/A,  N=199, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | N=4000 --> 199
  • ||||||||||  Enrollment open, Trial primary completion date, Surgery:  The Efficacy and Safety of Thunderbeat in Thyroid Surgery (clinicaltrials.gov) -  May 22, 2015   
    P=N/A,  N=1, Recruiting, 
    Recruiting --> Active, not recruiting | N=25 --> 8 | Trial primary completion date: Dec 2018 --> Sep 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Jun 2015
  • ||||||||||  prednisone / Generic mfg.
    Trial completion:  Short-term Prednisone to Treat STA Study(SPTSS) (clinicaltrials.gov) -  May 20, 2015   
    P4,  N=40, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Jun 2015 Recruiting --> Completed
  • ||||||||||  vatalanib (PTK787) / Novartis, Bayer
    Trial primary completion date:  Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Apr 19, 2015   
    P1,  N=96, Active, not recruiting, 
    Recruiting --> Completed | Initiation date: Dec 2010 --> May 2011 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Lumigan (bimatoprost) / Senju, AbbVie
    Enrollment closed:  Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) (clinicaltrials.gov) -  Apr 16, 2015   
    P4,  N=31, Active, not recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, Surgery:  Acupuncture for Reduction of Inflammation (clinicaltrials.gov) -  Apr 16, 2015   
    P=N/A,  N=20, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Apr 2015 --> Oct 2014
  • ||||||||||  Trial primary completion date:  Thyroid Disease Serum Repository (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=1000, Recruiting, 
    Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Apr 2015 --> Oct 2014 Trial primary completion date: May 2015 --> May 2016